ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in ENDRA Life Sciences Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q4 2021
- Shares held
- 3.95M
- −473.2K (−10.7%) vs. Q4 2021
- Total value
- $1.54M
- −$1.52M (−49.7%) vs. Q4 2021
- New holders
- 4
- 4 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 1,309 | $0 | 0.00% | +3+0.2% | Added |
| Geneos Wealth Management Inc. | 1,500 | $0 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Worth Asset Management, LLC | 4,200 | $1.00K | 0.00% | +4,200 | New |
| Skandinaviska Enskilda Banken AB (publ) | 5,000 | $2.00K | 0.00% | +5,000 | New |
| Royal Bank of Canada | 15,310 | $6.00K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 17,111 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 21,421 | $8.00K | 0.00% | +21,421 | New |
| UBS Group AG | 28,200 | $11.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 44,037 | $17.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 56,777 | $22.0K | 0.00% | +56,777 | New |
| Northern Trust Corp | 63,378 | $25.0K | 0.00% | 00.0% | Unchanged |
| 55I, LLC | 88,850 | $35.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 103,659 | $40.0K | 0.00% | −4,950−4.6% | Reduced |
| State Street Corp | 105,691 | $41.0K | 0.00% | +9,191+9.5% | Added |
| Geode Capital Management, LLC | 323,679 | $126.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 349,300 | $136.0K | 0.00% | +132,220+60.9% | Added |
| GWM Advisors LLC | 660,411 | $258.0K | 0.00% | −7,286−1.1% | Reduced |
| Morgan Stanley | 850,573 | $332.0K | 0.00% | +6,999+0.8% | Added |
| Vanguard Group Inc | 1,207,812 | $471.0K | 0.00% | −503,959−29.4% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −72,381−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −70,854−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −49,508−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −49−100.0% | Sold out |